Sivik Global Healthcare LLC Cuts Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Sivik Global Healthcare LLC decreased its stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 37.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 125,000 shares of the company's stock after selling 75,000 shares during the period. Surgery Partners makes up 1.6% of Sivik Global Healthcare LLC's portfolio, making the stock its 27th largest holding. Sivik Global Healthcare LLC owned approximately 0.10% of Surgery Partners worth $2,969,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. State of Wyoming increased its position in shares of Surgery Partners by 94.4% during the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock worth $85,000 after purchasing an additional 1,943 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. boosted its holdings in shares of Surgery Partners by 12.1% in the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock worth $91,000 after acquiring an additional 465 shares in the last quarter. GAMMA Investing LLC grew its position in Surgery Partners by 7,902.7% during the 1st quarter. GAMMA Investing LLC now owns 8,883 shares of the company's stock worth $211,000 after acquiring an additional 8,772 shares during the last quarter. Tower Research Capital LLC TRC raised its position in Surgery Partners by 279.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock valued at $228,000 after purchasing an additional 7,925 shares during the last quarter. Finally, Empowered Funds LLC bought a new stake in shares of Surgery Partners during the fourth quarter worth $245,000.

Analysts Set New Price Targets

Several research analysts have issued reports on SGRY shares. Barclays reduced their price objective on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 27th. Macquarie dropped their price objective on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a report on Tuesday, March 11th. Benchmark reaffirmed a "buy" rating and issued a $35.00 target price on shares of Surgery Partners in a research note on Monday, April 21st. Finally, Royal Bank Of Canada reissued an "outperform" rating and set a $35.00 price target on shares of Surgery Partners in a research note on Tuesday, March 25th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, Surgery Partners presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.56.

Surgery Partners Price Performance

NASDAQ SGRY traded up $0.91 during trading on Tuesday, hitting $21.11. 2,784,801 shares of the company's stock were exchanged, compared to its average volume of 1,185,769. Surgery Partners, Inc. has a fifty-two week low of $18.87 and a fifty-two week high of $33.97. The company has a current ratio of 1.89, a quick ratio of 1.73 and a debt-to-equity ratio of 1.09. The stock's 50 day moving average price is $22.34 and its two-hundred day moving average price is $22.65. The company has a market cap of $2.71 billion, a PE ratio of -13.80 and a beta of 1.93.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.04). The company had revenue of $776.00 million for the quarter, compared to the consensus estimate of $777.77 million. Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 6.10%. The firm's revenue was up 8.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.10 earnings per share. Research analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.